Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gozewijn D Laverman

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Journal of Hypertension|August 19, 2003
Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?Gozewijn D Laverman, Giuseppe Remuzzi
Current Hypertension Reports|October 4, 2011
Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockadeGozewijn D Laverman, Gerjan Navis
Journal of the American Society of Nephrology : JASN|December 20, 2003
ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection?Gozewijn D Laverman, Giuseppe Remuzzi, Piero Ruggenenti
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 14, 2003
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?Gozewijn D Laverman, Dick de Zeeuw, Gerjan Navis
Current Opinion in Nephrology and Hypertension|August 29, 2009
Benefits of dietary sodium restriction in the management of chronic kidney diseaseJan A Krikken, Gozewijn D Laverman, Gerjan Navis
Endocrinology, Diabetes & Metabolism Case Reports|November 6, 2023
Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODYNicole Oosterom, Niala den Braber, Gozewijn D Laverman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 24, 2010
Reversible effects of diuretics added to renin-angiotensin-aldosterone system blockade: impact on interpretation of long-term kidney function outcomeMaartje C J Slagman, Gerjan Navis, Gozewijn D Laverman
Current Opinion in Nephrology and Hypertension|January 7, 2010
Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal diseaseMaartje C J Slagman, Gerjan Navis, Gozewijn D Laverman
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 25, 2019
Escaping residual albuminuria in hypertension: should we start eplerenone or reduce salt intake?Martin H de Borst, Gozewijn D Laverman, Gerjan Navis
Lancet (London, England)|March 28, 2003
The COOPERATE trialLiffert Vogt, Gozewijn D Laverman, Dick de Zeeuw, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Journal of Hypertension|August 19, 2003
Antihypertensive therapy in chronic renal disease: a place for sympathicolytic agents?Gozewijn D Laverman, Giuseppe Remuzzi
Current Hypertension Reports|October 4, 2011
Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockadeGozewijn D Laverman, Gerjan Navis
Journal of the American Society of Nephrology : JASN|December 20, 2003
ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection?Gozewijn D Laverman, Giuseppe Remuzzi, Piero Ruggenenti
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 14, 2003
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?Gozewijn D Laverman, Dick de Zeeuw, Gerjan Navis
Current Opinion in Nephrology and Hypertension|August 29, 2009
Benefits of dietary sodium restriction in the management of chronic kidney diseaseJan A Krikken, Gozewijn D Laverman, Gerjan Navis
Endocrinology, Diabetes & Metabolism Case Reports|November 6, 2023
Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODYNicole Oosterom, Niala den Braber, Gozewijn D Laverman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 24, 2010
Reversible effects of diuretics added to renin-angiotensin-aldosterone system blockade: impact on interpretation of long-term kidney function outcomeMaartje C J Slagman, Gerjan Navis, Gozewijn D Laverman
Current Opinion in Nephrology and Hypertension|January 7, 2010
Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal diseaseMaartje C J Slagman, Gerjan Navis, Gozewijn D Laverman
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 25, 2019
Escaping residual albuminuria in hypertension: should we start eplerenone or reduce salt intake?Martin H de Borst, Gozewijn D Laverman, Gerjan Navis
Lancet (London, England)|March 28, 2003
The COOPERATE trialLiffert Vogt, Gozewijn D Laverman, Dick de Zeeuw, et al.
Pageof 11